High materiality8/10
Iovance Biotherapeutics price target raised to $13 from $11 at Barclays
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Barclays lifts IOVA target to $13 from $11; current price is $6.21.
- Target raised to $13 from $11 by Barclays
- Current price $6.21
Key facts
- 01
Target: $13
- 02
Posted price: $6.21
- 03
Analyst firm: Barclays
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.